The prevalence of sarcopenia was 22.8% (males: 29.3% and females: 16.6%); in group < 60 ages: 6.9%, ≥ 60 ages: 27.8%; in group > 10 years: 28.6%, ≤ 10 years: 17.0%; in group hypertension: 26.9%, nonhypertension: 17.5%; in group BMI ≤ 22.5: 31.1%, BMI > 22.5: 17.3%; in group eGFR < 60ml / min/1.73 m 2: 39.3%, ≥ 60ml / min/1.73 m 2: 7.6%.